This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Degenhardt, Y. Y.
Right arrow Articles by Silverstein, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degenhardt, Y. Y.
Right arrow Articles by Silverstein, S. J.

 Previous Article  |  Next Article 

Journal of Virology, January 2001, p. 151-160, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.151-160.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Gps2, a Protein Partner for Human Papillomavirus E6 Proteins

Yan Yan Degenhardt1 and Saul J. Silverstein2,*

Departments of Pharmacology1 and Microbiology,2 Columbia University, New York, New York 10032

Received 21 July 2000/Accepted 10 October 2000

We have used the yeast two-hybrid system to screen a cDNA library prepared from normal human epidermal keratinocytes and identified protein partners for human papilloma virus (HPV) E6 proteins. A clone that encoded Gps2 interacted with E6 proteins from HPVs of high and low oncogenic risk. The specificity of these reactions was verified and the regions of E6 that were required for interaction were mapped. Steady-state and pulse-chase analyses of cells cotransfected with DNAs expressing E6 from either HPV6 or HPV18 and Gps2 demonstrated that the E6 proteins induced the degradation of Gps2 in vivo but not in vitro. Gps2 exhibited transcriptional activation activity, and high-risk E6 suppressed this activity.


* Corresponding author. Mailing address: Department of Microbiology, Columbia University, 701 W. 168th St., New York, NY 10032. Phone: (212) 305-8149. Fax: (212) 305-5106. E-mail: sjs6{at}columbia.edu.


Journal of Virology, January 2001, p. 151-160, Vol. 75, No. 1
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.1.151-160.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zhang, D., Harry, G. J., Blackshear, P. J., Zeldin, D. C. (2008). G-protein Pathway Suppressor 2 (GPS2) Interacts with the Regulatory Factor X4 Variant 3 (RFX4_v3) and Functions as a Transcriptional Co-activator. J. Biol. Chem. 283: 8580-8590 [Abstract] [Full Text]  
  • Storrs, C. H., Silverstein, S. J. (2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol. 81: 4080-4090 [Abstract] [Full Text]  
  • Zhang, Y., Dasgupta, J., Ma, R. Z., Banks, L., Thomas, M., Chen, X. S. (2007). Structures of a Human Papillomavirus (HPV) E6 Polypeptide Bound to MAGUK Proteins: Mechanisms of Targeting Tumor Suppressors by a High-Risk HPV Oncoprotein. J. Virol. 81: 3618-3626 [Abstract] [Full Text]  
  • Muller-Schiffmann, A., Beckmann, J., Steger, G. (2006). The e6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.. J. Virol. 80: 8718-8728 [Abstract] [Full Text]  
  • Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaic, V., Kelley, M. L., Baker, C. C., Huibregtse, J., Schlegel, R. (2005). The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein. J. Biol. Chem. 280: 10807-10816 [Abstract] [Full Text]  
  • Magal, S. S., Jackman, A., Ish-Shalom, S., Botzer, L. E., Gonen, P., Schlegel, R., Sherman, L. (2005). Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J. Gen. Virol. 86: 611-621 [Abstract] [Full Text]  
  • Lee, C., Laimins, L. A. (2004). Role of the PDZ Domain-Binding Motif of the Oncoprotein E6 in the Pathogenesis of Human Papillomavirus Type 31. J. Virol. 78: 12366-12377 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 68: 362-372 [Abstract] [Full Text]  
  • Oh, S. T., Longworth, M. S., Laimins, L. A. (2004). Roles of the E6 and E7 Proteins in the Life Cycle of Low-Risk Human Papillomavirus Type 11. J. Virol. 78: 2620-2626 [Abstract] [Full Text]  
  • Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G., Wazer, D., Band, H., Band, V. (2002). Human Papilloma Virus 16 E6 Oncoprotein Inhibits Retinoic X Receptor-mediated Transactivation by Targeting Human ADA3 Coactivator. J. Biol. Chem. 277: 45611-45618 [Abstract] [Full Text]  
  • Nguyen, M., Song, S., Liem, A., Androphy, E., Liu, Y., Lambert, P. F. (2002). A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo. J. Virol. 76: 13039-13048 [Abstract] [Full Text]  
  • Park, R. B., Androphy, E. J. (2002). Genetic Analysis of High-Risk E6 in Episomal Maintenance of Human Papillomavirus Genomes in Primary Human Keratinocytes. J. Virol. 76: 11359-11364 [Abstract] [Full Text]  
  • Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3. Mol. Cell. Biol. 22: 5801-5812 [Abstract] [Full Text]  
  • Gao, Q., Kumar, A., Singh, L., Huibregtse, J. M., Beaudenon, S., Srinivasan, S., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus E6-induced Degradation of E6TP1 Is Mediated by E6AP Ubiquitin Ligase. Cancer Res. 62: 3315-3321 [Abstract] [Full Text]  
  • Degenhardt, Y. Y., Silverstein, S. (2001). Interaction of Zyxin, a Focal Adhesion Protein, with the E6 Protein from Human Papillomavirus Type 6 Results in Its Nuclear Translocation. J. Virol. 75: 11791-11802 [Abstract] [Full Text]